INSIDER · CIK 1230484
Kenyon Lawrence A
Chief Financial Officer, Director at Outlook Therapeutics, Inc. (OTLK)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$0.00Sold on the market
1Companies
Aug 14, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 202619:39 | Aug 14, 2026 | OTLKOutlook Therapeutics, Inc. | Chief Financial Officer, Director | P · Buy | — | +101,010 | 106,956 | +1699% | — | — | — |